Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is treatment with tumor necrosis factor inhibitors safe in pregnant patients?

Nature Clinical Practice Rheumatology volume 3, pages 548–549 (2007)Cite this article

boxed-textRoux CH et al. (2007) Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy. Rheumatology 46: 695–698

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hunt JS et al. (1996) Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 54: 554–562

    Article  CAS  Google Scholar 

  2. Simister NE (2003) Placental transport of immunoglobulin G. Vaccine 21: 3365–3369

    Article  CAS  Google Scholar 

  3. Carter JD et al. (2006) Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J Rheumatol 33: 1014–1017

    PubMed  Google Scholar 

  4. Skomsvoll JF et al. (2007) Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation. Nat Clin Pract Rheumatol 3: 156–164

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Weill Medical College of Cornell University Medicine, Rheumatology Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA sammaritan@hss.edu

Authors and Affiliations

  1. LR Sammaritano is an Associate Professor of Clinical Medicine at the Weill Medical College of Cornell University, Hospital for Special Surgery in New York, NY, USA.,

    Lisa R Sammaritano

Authors
  1. Lisa R Sammaritano
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sammaritano, L. Is treatment with tumor necrosis factor inhibitors safe in pregnant patients?. Nat Rev Rheumatol 3, 548–549 (2007). https://doi.org/10.1038/ncprheum0597

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0597

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing